BUZZ-Humana rises after Jefferies upgrades to 'buy'
Humana's shares rose 3.5% after Jefferies upgraded its rating to 'buy' and increased the price target to $313, citing the company's Stars diversification efforts. Jefferies also raised FY26 EPS estimates and expects Medicare Advantage membership to grow by 21%. Despite better-than-expected quarterly profits, Humana's shares have been under pressure due to lack of 2026 performance commentary. Currently, 9 out of 28 brokerages rate the stock as 'buy' or higher.
Health insurer Humana (HUM.N) shares rise 3.5% to $261.89
Jefferies upgrades to “buy” from “hold” and raises price target to $313, representing a 23.7% upside to the share’s last close
Attributes company’s Stars diversification efforts for the bump up
Brokerage raises FY26 EPS estimates to $14.19 vs $11.18 previously
Also expects Medicare Advantage membership to grow by 21%
Shares have remained under pressure since HUM last month did not provide performance commentary for 2026, despite reporting better-than-expected quarterly profit
9 of 28 brokerages rate the stock “buy” or higher, 18 “hold” and 1 “sell”; their median PT is $289 - LSEG data
Stock is marginally down for the year, though last close
